International Projects

Pathway complexities of protein misfolding in neurodegenerative diseases: a novel approach to risk evaluation and model development (REfraME)
Program: H2020-EU.3.1, Ref No.: 643417
Project Coordinator: Giuseppe Legname, SISSA, Trieste, Italy
Duration: Jan 1, 2015 – Dec 31, 2018
Participating investigators:
  • A. Aguzzi (University of Zurich),
  • M. Goedert (MRC Laboratory of Molecular Biology, UK),
  • M. Jucker (DZNE, Germany),
  • G. Di Fede (IRCCS Foundation Carlo Besta Neurological Institute, Italy),
  • J-Y. Li (Lund University, Sweden)
  • M. Novak (NIU, Slovakia)
REfraME countries
SyDAD Synaptic Dysfunction in Alzheimer Disease
Program: H2020-EU.1.3.1., Ref No.: 676144
Project Coordinator: Bengt Winblad, KAROLINSKA INSTITUTET, Sweden
Duration: Nov 1, 2015 – Oct 31, 2019
SyDAD countries
Repetitive Subconcussive Head Impacts -Brain Alterations and Clinical Consequences
Program: ERANET
Project Coordinator: Inga Katharina Koerte, MD PhD, Ludwig-Maximilians-Universität München, Department of Child and Adolescent Psychiatry, Psychosomatics, Germany
Project Co-investigator: Assoc. Prof. Peter Filipcik, RNDr, PhD
Duration: January 1, 2017 – 31 December 2019
ERANET
 

Neurovascular damage determines disease pathophysiology in pediatric mild traumatic brain injury: source of new biomarkers
Neu-Vasc – Neurovaskulárne poškodenie určuje patofyziológiu ochorenia u detských pacientov po traumatickom poškodení mozgu: zdroj nových biomarkerov
Program: ERANET
Project leader: doc. RNDr. Filipčík Peter CSc.
Duration: 1.1.2020 – 31.12.2022
Alzheimer’s disease data-driven insights on individual outcomes of importance
Sledovanie dôležitých individuálnych výstupov pacientov s Alzheimerovou chorobou
Program: Horizon 2020
Project leader: Dr. h. c. prof. MVDr. Novák Michal DrSc.
Duration: 1.5.2019 – 30.4.2022
Bridging the gap between science, education and enterprise in regenerative medicine
Bridging the gap between science, education and enterprise in regenerative medicine
Program: Multilateral – other
Project leader: doc. MVDr. Čížková Daša DrSc.
Duration: 1.10.2020 – 20.3.2022
Nanosystems conjugated with antibody fragments for treating brain infections
Nanosystémy konjugované s fragmentami protilátok na liečbu infekcií mozgu
Program: ERANET
Project leader: doc. MVDr. Bhide Mangesh Ramesh PhD.
Duration: 1.1.2019 – 31.12.2021
The tryptophan kynurenine pathway – therapeutic strategy for neuroprotection in tauopathies
Tryptofán kynurenínová signálna dráha v tauopátiách a jej neuroprotektívna úloha s využitím v terapii
Program: ICGEB
Project leader: PharmDr. Kováč Andrej PhD.
Duration: 1.1.2019 – 31.12.2021